Skip to main content

Update: SciSparc To Spin Off Pharmaceutical Activities Into New Subsidiary

The jury is out on how well SciSparc will do in executing its restructuring plan, but the company has no other choice.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.